Table II.
Ovarian and endocrine parameters in cycles before and after PRP treatment.
| Group 1a |
Group 2b |
|||||
|---|---|---|---|---|---|---|
| N | Pre-PRP | Post-PRP | N | Pre-PRP | Post-PRP | |
| Antral follicle count (n) | 52 | 4.4 ± 3.2 | 4.3 ± 3.4 | 26 | 1.9 ± 2.1 | 3.5 ± 3.2** |
| Maximal lead follicle (mm) | 52 | 11.4 ± 5.5 | 12.6 ± 4.5 | 26 | 8.6 ± 6.6 | 10.4 ± 5.8 |
| Day-2 FSH (mIU/ml) | 51 | 22.3 ± 17.8 | 23.4 ± 22.1 | 26 | 55.96 ± 40.7 | 68.12 ± 48.8 |
| Day-2 estradiol (pg/ml) | 51 | 51.6 ± 76.7 | 47.1 ± 28.7 | 26 | 50.4 ± 35.0 | 56.6 ± 40.7 |
| AMH (ng/ml) | 51 | 0.31 ± 0.49 | 0.30 ± 0.65 | 26 | 0.08 ± 0.20 | 0.19 ± 0.20 |
| Peak estradiol (pg/ml) | 48 | 209 ± 197 | 205 ± 166 | 23 | 127 ± 133 | 157 ± 280 |
| Oocytes retrieved (count) | 51 | 1.7 ± 2.4 | 1.5 ± 1.7 | 26 | 0.4 ± 0.9 | 0.8 ± 2.6 |
a
Group 1—regular menstrual cycles; bGroup 2—irregular menstrual cycles or amenorrhea.
**
0.002.
AMH, anti-mullerian hormone; PRP, platelet rich plasma.